Skip to main content

Effects of GnRH Agonist-Induced Ovarian Suppression on Calcium Homeostasis and Bone Metabolism in Premenstrual Women

  • Chapter
GnRH Analogues in Cancer and Human Reproduction

Abstract

In 1940, Albright et al [1] first observed an association between estrogen deprivation and loss of bone mass. Bone loss may be attributed to an increase in the sensitivity of bone to the resorbing action of parathyroid hormone (PTH), 1,25-dihydroxy-vitamin D3 or other bone-resorbing agents [2, 3], Higher values for calcium in serum and urinary excretion of calcium [4, 5] have been observed in postmenopausal women, supporting the theory of an increased bone resorption. The greatest loss of bone mass occurs during the first four to five years after the menopause [6] and affects predominantly trabecular bone [7, 8]. Estrogen replacement therapy prevents postmenopausal bone loss and attendant osteoporotic fractures [9–12], Any factor that irreversibly decreases bone mass in premenopausal women predisposes to the disease of osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albright, F, Smith, PH, Richardson, AM (1941). Postmenopausal osteoporosis: its clinical features. JAMA, 116, 2465

    Google Scholar 

  2. Heaney, RP (1965). A unified concept of osteoporosis. Am J Med, 39. 877

    Article  PubMed  CAS  Google Scholar 

  3. Jasani, C, Nordin, BEC, Smith, DA and Swanson, I (1965). Spinal osteoporosis and the menopause. Proc Roy Soc, 58, 441

    CAS  Google Scholar 

  4. Young, MM and Nordin, BEC (1967). Effects of natural and artificial menopause on plasma and urinary calcium and phosphorus. Lancet, i, 118

    Article  Google Scholar 

  5. Gallagher, JC, Young, MM and Nordin, BEC (1972). Effects of artificial menopause on plasma and urine calcium and phosphate. Clin Endocrinol, 1, 57

    Article  CAS  Google Scholar 

  6. Lindsay, R and Herrington, BS (1983). Estrogens and osteoporosis. Sem Reprod Endocrinol, 1, 55

    Article  Google Scholar 

  7. Horsman, A, Nordin, BEC, Aaron, J and Marshall, DH (1981). Cortical and trabecular osteoporosis and their relation to fractures in the elderly. In: DeLuca, HF, Frost, HM, Jee, WSS, Johnston, CC and Parfitt, AM (eds.) “Osteoporosis — Recent Advances in Pathogenesis and Treatment”, p.175. (Baltimore: University Park Press)

    Google Scholar 

  8. Genant, HK, Cann, CE, Ettinger, B and Gordan, GS (1982). Quantative computed tomography of vertebral spongiosa: a sensitive method for detecting early bone loss after oophorectomy. Ann Intern Med, 97, 699

    PubMed  CAS  Google Scholar 

  9. Lindsay, R, Hart, DM, Aitken, JM, MacDonal, AB, Anderson, JB and Clarke, AC (1976). Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet, 1, 1038

    Article  PubMed  CAS  Google Scholar 

  10. Hutchinson, TA, Polansky, SM and Feinstein, AR (1979). Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. Lancet, 2, 705

    Article  PubMed  CAS  Google Scholar 

  11. Diddle, AW and Smith IQ (1984). Postmenopausal osteoporosis: the role of estrogens. Southern Med J, 77, 868

    Article  PubMed  CAS  Google Scholar 

  12. Christiansen, C, Christensen, MS, McNair, P, Hagen, C, Stocklund, K-E and Transbol, I (1980). Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest, 10, 273

    Article  PubMed  CAS  Google Scholar 

  13. Matsuo, H, Arimura, A, Nair, RMG and Schally, AV (1971). Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method. Biochem Biophys Res Commun, 45, 822

    Article  PubMed  CAS  Google Scholar 

  14. Schally, AV, Arimura, A, Baba, Y, Nair, RMG, Matsuo, H, Redding, TW and Debeljuk, L (1971). Isolation and properties of FSH and LH-releasing hormone. Biochem Biophys Res Commun, 43, 393

    Article  PubMed  CAS  Google Scholar 

  15. Price, PA, Parthemore, JG and Deftos, LJ (1980). New biochemical marker for bone metabolism. J Clin Invest, 66, 878

    Article  PubMed  CAS  Google Scholar 

  16. Deftos, LJ, Parthemore, JF and Price, PA (1981). The measurement by radioimmunoassay in plasma of bone GLA during treatment of bone diseases. Calcif Tissue Int, 33, 307

    Google Scholar 

  17. Bothe, V, Schmidt-Gayk, H, Armbruster, F-P and Mayer, E (1984). Assay for the diagnosis of hyper- and hypovitaminosis D. Ärztl Lab, 30, 151

    CAS  Google Scholar 

  18. Scharla, S, Schmidt-Gayk, H, Reichel, H and Mayer, E (1984). A sensitive and simplified radioimmunoassay for 1,25-dihydroxyvitamin D3. Clin Chim Acta, 142, 325

    Article  PubMed  CAS  Google Scholar 

  19. Bouillon, R, Van Baelen, H, Rombauts, W and De Moor, P (1976). Purification and characterisation of the human serum binding protein for 25-hydroxyvitamin D3 (transcalciferin): identity with group specific component (Gc). Eur J Biochem, 66, 285

    Article  PubMed  CAS  Google Scholar 

  20. Cameron, JR, and Sorenson, J (1963). Meaurement of bone mineral in vivo: an improved method. Science, 142, 230

    Article  PubMed  CAS  Google Scholar 

  21. Mazess, RB, Hanson, J, Kan, W, Madsen, M. Pele, N, Wilson, CR and Witt, RM (1974). Progress in dual photon absorptiometry of bone. In: Schmeling, P (ed.) “Proceedings, Symposium on Bone Mineral Determinations”, p. 40. (Studsvik Sweden: Aktiebolaget Atomenergi Publication)

    Google Scholar 

  22. Riggs, BL, Wahner, HW, Dunn, WL, Mazess, RB, Offord, KP and Melton III, LJ (1981). Differential changes in bone mineral density of the appendicular skeleton with aging: relationship to spinal osteoporosis. J Clin Invest, 67, 328

    Article  PubMed  CAS  Google Scholar 

  23. Riggs, BL, Wahner, HW, Seemen, E, Offord, KP, Dunn, WL, Mazess, RB, Johnson, KA and Melton, LJ, III (1982). Changes in bone mineral density of the proximal femur and spine with aging. J Clin Invest, 70, 716

    Article  PubMed  CAS  Google Scholar 

  24. Nordin, BEC (1976). In: Van Keep, PA, Greenblatt, RB and Furnet, MA (eds.) “Consensus on Menopausal Research”, p.48 (Lancaster: MTP Press)

    Google Scholar 

  25. Gallagher, JC, Riggs, BL, Jerpbak, M, and Arnaud, CD. (1980). The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med, 95, 373

    PubMed  CAS  Google Scholar 

  26. Castillo, L, Tanaka, Y, DeLuca, HF and Sundle, ML (1977). The stimulation of 25-hydroxyvitamin D3-hydroxy1ase by estrogen. Arch Biochem Biophys, 179, 211

    Article  PubMed  CAS  Google Scholar 

  27. Gallagher, JC, Riggs, BL, and DeLuca, HF (1980). The effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab, 51, 1359

    Article  PubMed  CAS  Google Scholar 

  28. Gudmundsson, JA, Ljunghall, S, Bergquist, C, Wide, L and Nillius, SJ (1987). Increased bone turnover during gonadotropin releasing hormone superagonist-induced ovulation inhibition. J Clin Endocrinol Metab, 65, 159

    Article  PubMed  CAS  Google Scholar 

  29. Steingold, KA, Lu, JKH, Randle, D, Moore, JG, Judd, HL and Meldrum, DR (1985). Treatment of endometriosis with a long acting GnRH analog — a blind evaluation. Presented at the 32nd Annual Meeting, Society for Gynecology Investigation, Phoenix, Arizona

    Google Scholar 

  30. Delmas, PD, Brown, JP, Malaval, L, Eduard, C and Meunier, PJ (1984). In: Cohn, Fujita, Potts and Talmage (eds.) “Endocrine control of bone and calcium metabolism”, p.73. (Amsterdam: Elsevier Science Publishers)

    Google Scholar 

  31. Price, PA, Parthemore, JG and Deftos, LJ (1980). New biochemical maker for bone metabolism. J Clin Invest, 66, 878

    Article  PubMed  CAS  Google Scholar 

  32. Delmas, PD, Wahner, HW, Mann, KG, and Riggs, BL (1983). Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med, 102, 470

    PubMed  CAS  Google Scholar 

  33. Genant, HK, and Cann, CE (1981). Vertebral mineral determination using quantitative computed tomography. In: DeLuca, HF, Frost, HM, Jee, WSS, Johnston, CC and Parfitt, AM (eds.) “Osteoporosis: Recent advances in pathogenesis and treatment”, p.37. (Baltimore: University Park Press)

    Google Scholar 

  34. Devogelaer, JP, Huaux, JP, Nagant de Deuxchaisness, C, Donnez, J and Thomas, K (1987). Differential effects of the GnRH agonist buserelin on the axial and the appendicular skeleton. Presented at the 9th Annual Scientific Meeting of the American Society for Bone and Mineral Research, June 6–9, Indianapolis

    Google Scholar 

  35. Cann, CE, Martin, MC, Genant, HK and Jaffe, RB (1984). Decreased spinal mineral content in amenorrheic women. JAMA, 251, 626

    Article  PubMed  CAS  Google Scholar 

  36. Parfitt, AM (1979). Quantum concept of bone remodeling and turnover: implications for the pathogenesis of osteoporosis. Calcif Tissue Int, 28, 1

    Article  PubMed  CAS  Google Scholar 

  37. Cann, CE, Henzl, M, Heinrichs, J and Burry, K (1987). Calcium aggravates GnRH agonist-induced bone loss. Presented at the 9th Annual Scientific Meeting of the American Society for Bone and Mineral Research, June 6–9, Indianapolis

    Google Scholar 

  38. Matta, WH, Shaw, RW, Hesp, R and Katz, D (1987). Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women. Brit Med J, 294, 1523

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Waibel, S. et al. (1990). Effects of GnRH Agonist-Induced Ovarian Suppression on Calcium Homeostasis and Bone Metabolism in Premenstrual Women. In: Vickery, B.H., Lunenfeld, B. (eds) GnRH Analogues in Cancer and Human Reproduction. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-0725-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-0725-6_17

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6811-6

  • Online ISBN: 978-94-009-0725-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics